XTX Topco Ltd Makes New Investment in Enhabit, Inc. (NYSE:EHAB)

XTX Topco Ltd purchased a new stake in Enhabit, Inc. (NYSE:EHAB) in the third quarter, HoldingsChannel reports. The firm purchased 15,555 shares of the company’s stock, valued at approximately $123,000.

Several other large investors have also recently bought and sold shares of EHAB. FMR LLC raised its holdings in shares of Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after acquiring an additional 1,967 shares during the period. Quarry LP grew its stake in Enhabit by 242.2% in the second quarter. Quarry LP now owns 3,703 shares of the company’s stock valued at $33,000 after purchasing an additional 2,621 shares in the last quarter. Gladius Capital Management LP grew its stake in shares of Enhabit by 78.2% in the third quarter. Gladius Capital Management LP now owns 6,259 shares of the company’s stock valued at $49,000 after buying an additional 2,747 shares in the last quarter. Stoneridge Investment Partners LLC acquired a new position in shares of Enhabit during the 3rd quarter worth about $81,000. Finally, Canada Pension Plan Investment Board bought a new stake in Enhabit in the second quarter valued at approximately $93,000.

Analyst Ratings Changes

A number of research firms have recently issued reports on EHAB. Leerink Partners restated a “market perform” rating and set a $8.00 target price (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. Jefferies Financial Group raised Enhabit from a “hold” rating to a “buy” rating and increased their target price for the stock from $8.25 to $9.50 in a report on Monday, December 9th. One analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $8.75.

Insider Buying and Selling

In other Enhabit news, Director Stuart M. Mcguigan purchased 15,000 shares of the firm’s stock in a transaction on Tuesday, December 10th. The stock was purchased at an average cost of $8.81 per share, for a total transaction of $132,150.00. Following the acquisition, the director now owns 46,810 shares in the company, valued at approximately $412,396.10. The trade was a 47.15 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jeffrey Bolton bought 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 12th. The shares were acquired at an average cost of $8.69 per share, with a total value of $34,760.00. Following the purchase, the director now directly owns 98,144 shares of the company’s stock, valued at $852,871.36. This trade represents a 4.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.90% of the stock is currently owned by insiders.

Enhabit Trading Down 0.6 %

EHAB opened at $7.65 on Friday. The company’s 50 day moving average is $7.64 and its 200-day moving average is $8.27. The company has a market cap of $384.67 million, a P/E ratio of -3.30 and a beta of 1.89. Enhabit, Inc. has a 1-year low of $6.85 and a 1-year high of $11.74. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85.

Enhabit (NYSE:EHAB) last posted its earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $253.60 million during the quarter, compared to the consensus estimate of $261.69 million. During the same quarter in the prior year, the business posted $0.03 earnings per share. Equities research analysts predict that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.